17 December 2021
ATRO Medical, a Radboudumc and DSM spin-off, is based in Uden and has an office in Nijmegen, where the company benefits from the expertise and facilities of Radboudumc. Jan Hunik, co-founder and CEO: "I am very pleased with this investment round and welcomes the trust in the Trammpolin® device at this stage of the development. The funds raised will enable the company to execute a second clinical study to demonstrate its potential to improve the quality of lives of patients".
Read the full article on ATRO Medical
image courtesy of ATRO Medical
Related news items
EU grant awarded to development of meniscus prosthesis € 2.5 million for ATRO Medical
8 June 2022 The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation. read more
Radboudumc and Terumo Europe N.V. sign collaboration agreement
3 June 2022 Together, the two partners will improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads. read more
More accurate surgery with the Anatomy Projector
30 May 2022 The Anatomy Projector, developed at the Radboudumc, allows surgeons to operate much more accurately with projected augmented reality. read more
Investment in ARNE helps neonatologists make better decisions when treating newborn babies
28 April 2022 ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child. read more
